Abiomed Gets FDA Approval For New Heart Pump
Stock quotes in this article:
ABMD
DANVERS, Mass. (AP) Abiomed Inc. said Wednesday the Food and Drug Administration approved its newest version of the Impella heart pump.
The stock jumped 60 cents, or 10.8 percent, to $6.15 in after-hours trading, following the announcement. Shares rose 2 cents to close at $5.55 during the regular trading session. The company said the FDA approved the Impella 5.0, which is similar to the Impella 2.5 approved in June. The newest version provides circulatory support for periods of up to six hours. It is a catheter-based pump that helps reduce the workload on the heart muscle.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,452.68 | 1,109.24 | 2,185.03 | 33.23 |
Oil *
77.73
|
|
DOWN
18.90
|
UP
0.38
|
UP
9.22
|
UP
0.48
|
10 Yr
3.32%
SPDR Gold
119.18
|
|
-0.18%
|
+0.03%
|
+0.42%
|
+1.47%
|
Data delayed 20 minutes |
